How has Frank Thelen's fund been doing so far?

Frank Thelen's 10XDNA fund has now been on the market for 4 months and has lost around 10% in value since the first day of trading (cf. https://www.onvista.de/fonds/10XDNA-DISRUPTIVE-TECHNOLOGIES-R-EUR-DIS-Fonds-DE000DNA10X3).

But what is the reason for this? Officially, the fund has no benchmark with which we can compare the performance. But let's take a look at Cathie Woods ARK Innovation ETF, which uses a similar investment universe.

Since the beginning of September, the share price has fallen from €104.80 to €82.15, a drop of almost 22%. Frank Thelen and his team are not the only ones who are currently failing to deliver performance with their focus on disruptive innovations.

The performance of Bitcoin and Ethereum, which are each included in the fund at around 4%, has also not made any major price jumps in recent months and could not save the return.

So what can be concluded from this short-term performance now:

Actually, what was already known before. Frank Thelen's fund is heavily dependent on how volatile and risky innovative companies perform. Thus, the product is also conceivably unsuitable for beginners taking their first steps into the investment world. To draw a conclusion about the success of the fund and to evaluate the performance, the product is still too young. However, I would still not invest here, as the fund is clearly too concentrated on a few volatile stocks for me.

What do you think about the fund and its performance?